Comparison between Hindustan Laboratories IPO and Rodec Pharma IPO.
Hindustan Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Rodec Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Hindustan Laboratories IPO | Rodec Pharma IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Choice Capital Advisors Pvt.Ltd. | Khambatta Securities Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | ||
| Final Prospectus | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Hindustan Laboratories IPO is up to ₹0.00 Cr whereas the issue size of the Rodec Pharma IPO is up to ₹0.00 Cr. The final issue price of Hindustan Laboratories IPO is and of Rodec Pharma IPO is .
| Hindustan Laboratories IPO | Rodec Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 50,00,000 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 91,00,000 shares | 56,50,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,41,00,000 shares | 56,50,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Hindustan Laboratories IPO opens on , while Rodec Pharma IPO opens on . The closing date of Hindustan Laboratories IPO and Rodec Pharma IPO is , and , respectively.
Hindustan Laboratories IPO P/E ratio is , as compared to Rodec Pharma IPO P/E ratio of .
| Hindustan Laboratories IPO | Rodec Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Standalone)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 92.40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 33.13% | 40.94% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.28 | ₹8.08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 26.11% | 36.49% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Hindustan Laboratories IPO Retail Individual Investors (RII) are offered 0 shares while in Rodec Pharma IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Hindustan Laboratories IPO and 0 shares in Rodec Pharma IPO.
| Hindustan Laboratories IPO | Rodec Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Hindustan Laboratories IPO subscribed in total, whereas Rodec Pharma IPO subscribed .
